Evaluation of the expression of transcriptional factor NF-κB induced by phytic acid in colon cancer cells

Acta Poloniae Pharmaceutica - Drug Research

Volumn 65, Issue 6, 2008, Pages 697-702

  Kapral, Małgorzata ^a   Parfiniewicz, Beata ^a   Strzałka Mrozik, Barbara ^a   Zachacz, Agnieszka ^a   Wȩglarz, Ludmiła ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Colon cancer; mRNA quantification; NF B; Phytic acid; Real time QRT PCR

Indexed keywords

I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PHYTIC ACID; PROTEIN P50; SYNAPTOTAGMIN I; ANTINEOPLASTIC AGENT; I KAPPA B; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; TRANSCRIPTION FACTOR RELA;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL STRAIN CACO 2; COLON CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG MECHANISM; GENE EXPRESSION; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; COLON TUMOR; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME;

ANTINEOPLASTIC AGENTS; CACO-2 CELLS; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; I-KAPPA B PROTEINS; NF-KAPPA B P50 SUBUNIT; PHYTIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION, GENETIC;

EID: 61549131213     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Ferlay J., Autier P., Boniol M., Heanue M., Colombet M., Boyle P.: Ann. Oncol. 18, 581 (2007).
2. Vucenik I., Shamsuddin A.M.: J. Nutr. 133, 3778S (2003).
3. Vucenik I., Shamsuddin A.M.: Nutr. Cancer 55, 109 (2006).
4. Menniti F.S., Oliver K.G., Putney J.W., Shears S.B.: Trends Biochem. Sci. 18, 53 (1993).
5. Hayden M.S., Ghosh S.: Genes Dev. 18, 2195 (2004).
6. Shamsuddin A.M., Vucenik I., Cole K.E.: Life Sci. 61, 343 (1997).
7. Tian Y., Song Y.: World J. Gastroenterol. 12, 4137 (2006).
8. Jenab M., Thompson L.U.: Carcinogenesis 21, 1547 (2000).
9. Agarwal C., Dhanalakshmi S., Singh R.P., Agarwal R.: Neoplasia 6, 646 (2004).
10. Liao J., Seril D.N., Yang A.L., Lu G.G., Yang G.Y.: Carcinogenesis 28, 446 (2007).
11. Vucenik I., Passaniti A., Vitolo M.I., Tantivejkul K., Eggleton P., Shamsuddin A.M.: Carcinogenesis 25, 2115 (2004).
12. Wang C.Y., Mayo M.W., Korneluk R.G., Goeddel D.V., Baldwin A.S.: Science 281, 1680 (1998).
13. Guttridge D.C., Albanese C., Reuther J.Y., Pestell R.G., Baldwin A.S.: Mol. Cell Biol. 19, 5785 (1999).
14. Chilov D., Kukk E., Taira S., Jeltsch M., Kaukonen J., Palotie A., Joukov V., Alitalo K.: J. Biol. Chem. 272, 25176 (1997).
15. Agrawal A., Das K., Lerner N., Sathe S., Cicek M., Casey G., Sizemore N.: Oncogene 24, 1021 (2005).
16. Czyż M.: Post. Biochem. 51, 60 (2005).
17. Hayden M.S, Ghosh S.: Genes Dev. 18, 2195 (2004).
18. Yates L.L, Górecki D.C.: Acta Biochim. Pol. 53, 651 (2006).
19. Mayo M.W., Baldwin A.S.: Biochem. Biophys. Acta 1470, M55 (2000).
20. Inoue M., Matsuoka M., Yamaguchi K., Takatsuki K., Yoshida M.: Jpn. J. Cancer Res. 89, 53 (1998).
21. Singh R.P., Agrawal R.: Endocr. Relat. Cancer 13, 751 (2006).
22. Mori N., Fujii M., Ikeda S., Yamada Y., Tomonaga M., Ballard D. W., Yamamoto N.: Blood 93, 2360 (1999).
23. Sasaki N., Morisaki T., Hashizume K., et al.: Clin. Cancer Res. 7, 4136 (2001).
24. Wang W., Abbruzzese J.L., Evans D.B., Larry L., Cleary K.R., Chiao P.J.: Clin. Cancer Res. 5, 119 (1999).
25. Yu L.L., Yu H.G., Yu J.P., Luo H.S., Xu X.M., Li J.H.: World J. Gastroenterol. 10, 3255 (2004).
26. Scaife C.L., Kuang J., Wills J.C., et al.: Cancer Res. 62, 6870 (2002).
27. Lind D. S., Hochwald S. N., Malaty J., et al.: Surgery 130, 363 (2001).
28. Agarwal C., Dhanalakshmi S., Singh R.P., Agarwal R.: Anticancer Res. 23, 3855 (2003).
29. Ferry S., Matsuda M., Yoshida H., Hirata M.: Carcinogenesis 23, 2031 (2002).
30. Wíglarz L., Wawszczyk J., Orchel A., Jaworska-Kik M., Dzierżewicz Z.: Dig. Dis. Sci. 52, 93 (2007).